James Page, MD
Orthopaedic Surgery · Mountain View, CANPI 1720169352
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,138 of the $1,739 with a category attached, or 65.4%. Stryker accounts for 86.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $1,119 and has fallen 70.4% since, to $331 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in CA, where the typical reported total is $2,444.
Across 23 payments — averaging $75.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Johnson & Johnson$134
- Heraeus Medical, LLC.$41
- Medtronic$22
- Medical Device Business Services, Inc.$18
- Bioventus LLC$17
What the payments were for
- Travel & lodging$1,13865%
- Food & beverage$60135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 17 | $1,507 |
| Johnson & Johnson | 1 | $134 |
| Heraeus Medical, LLC. | 2 | $41 |
| Medtronic | 1 | $22 |
| Medical Device Business Services, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,739 in reported general payments places this provider in the 45th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 118 | $5,564 |
| Meloxicam | 183 | $840 |
| Gabapentin | 24 | $566 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $517 |
| Amoxicillin | 132 | $404 |
| Cephalexin | 14 | $385 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $272 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $216 |
| Oxycodone Hcl | 22 | $182 |
| Clindamycin Hcl | 31 | $124 |
| Ibuprofen | 15 | $112 |
| Prednisone | 15 | $87 |
| Tramadol Hcl | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mountain View
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.